Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium, 6824 [2019-03540]

Download as PDF 6824 Federal Register / Vol. 84, No. 40 / Thursday, February 28, 2019 / Notices Act on December 18, 2018 (83 FR 64878). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–03536 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division khammond on DSKBBV9HB2PROD with NOTICES Notice Pursuant to the National Cooperative Research and Production Act of 1993—Medical Technology Enterprise Consortium Notice is hereby given that, on January 28, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Medical Technology Enterprise Consortium (‘‘MTEC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Worcester Polytechnic Institute, Worcester, MA; Odyssey Systems Consulting Group, Ltd., Wakefiled, MA; Serpin Pharma, Nokesville, VA; Csymplicity Software Solutions, Inc., Allentown, PA; Qrons, Inc., Miami, FL; Intelligent Optical Systems, Inc., Torrance, CA; Abfero Pharmaceuticals Inc., Boston, MA; Shamrock Medical LLC, Phoenix, AZ; Sleep Care, Inc., Columbus, OH; Solution Guidance Corporation, Chantilly, VA; Existential Technologies, Inc., Chula Vista, CA; Bionica Labs LLC, Richmond, VA; Acell, Inc., Columbia, MD; Awarables Inc., Baltimore, MD; Onera BV, AB Eindhoven, THE NETHERLANDS; Healios, Inc., Flemington, NJ; Sanofi Pasteur, Swiftwater, PA; Biobeat Technologies Ltd., Petach Tikva, ISRAEL; Sana Health, Inc., San Anselmo, CA; ThoraXS Israel 17 Ltd, Tzur hadassa, ISRAEL; ADM Tronics Unlimited, Inc., Northvale, NJ; Aktivax, Inc., Broomfield, CO; XSurgical, Inc., Ipswich, MA; 98point6 Inc., Seattle, WA; University of Montana, Missoula, MT; Engility Corporation, Chantilly, VA; Entasis Therapeutics, Waltham, MA; Thomas Jefferson University, Philadelphia, PA; Gryphon Bio, Inc., South San Francisco, CA; Arcos, Inc., and Missouri City, TX; have been added as parties to this venture. VerDate Sep<11>2014 17:52 Feb 27, 2019 Jkt 247001 Also, Actuated Medical, Inc., Bellefonte, PA; Disarm Therapeutics, Inc., Cambridge, MA; Global Virus Network, Inc., Baltimore, MD; Health Research, Inc.—Wadsworth Center, Menands, NY; Parsons Government Services Inc., Pasadena, CA; Perceptronics Solutions, Inc., Sherman Oaks, CA; Tallinn University of Technology, Tallin, ESTONIA; The Regents of the University of Michigan, Ann Arbor, MI; and The Washington University, St. Louis, MO; have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and MTEC intends to file additional written notifications disclosing all changes in membership. On May 9, 2014, MTEC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 9, 2014 (79 FR 32999). The last notification was filed with the Department on October 12, 2018. A notice was published in the Federal Register pursuant to Section 6(b) of the Act on November 2, 2018 (83 FR 55204). Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. [FR Doc. 2019–03540 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Suzanne Morris, Chief, Premerger and Division Statistics Unit, Antitrust Division. Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993—Border Security Technology Consortium Notice is hereby given that, on February 1, 2019, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Border Security Technology Consortium (‘‘BSTC’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Benchmark Electronics, Inc., Scottsdale, AZ; Phelps2020, Knoxville, TN; Echodyne Corp., Kirkland, WA; Global Justice Solutions, LLC, San Antonio, TX; Cipher Tech PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 Solutions, Inc., Upper Nyack, NY; Blue Force Consulting, Westminster, MD; Harris Night Vision, Roanoke, VA; Next Century Corporation, Annapolis Junction, MD; Passport Systems, Inc., N Billerica, MA; Battelle Memorial Institute, Columbus, OH; RadiaBeam Technologies, LLC, Santa Monica, CA; CT Strategies, Washington, DC; Synapse Technology, Palo Alto, CA; and JDL Digital Systems DBA AirShip VMS, Redmond, WA, have been added as parties to this venture. Also, Michigan Technology University, Houghton, MI; DroneShield, Warrenton, VA; Tygart Technology, Inc., Fairmont, WV; Neos Diamant, Manassas, VA; Percipient.ai, Reston, VA; and TRI–COR Industries, Inc., Alexandria, VA, have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and BSTC intends to file additional written notifications disclosing all changes in membership. On May 30, 2012, BSTC filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on June 18, 2012 (77 FR 36292). The last notification was filed with the Department on November 27, 2018. A notice was published in the Federal Register pursuant to section 6(b) of the Act on December 19, 2018 (83 FR 65182). [FR Doc. 2019–03522 Filed 2–27–19; 8:45 am] BILLING CODE 4410–11–P DEPARTMENT OF JUSTICE Antitrust Division United States v. Learfield Communications, LLC, IMG College, LLC, and A–L Tier I LLC; Proposed Final Judgment and Competitive Impact Statement Notice is hereby given pursuant to the Antitrust Procedures and Penalties Act, 15 U.S.C. 16(b)–(h), that a proposed Final Judgment, Stipulation, and Competitive Impact Statement have been filed with the United States District Court for the District of Columbia in United States of America v. Learfield Communications, LLC, IMG College, LLC, and A–L Tier I LLC, Civil Action No. 1:19–cv–00389. On February 14, 2019, the United States filed a E:\FR\FM\28FEN1.SGM 28FEN1

Agencies

[Federal Register Volume 84, Number 40 (Thursday, February 28, 2019)]
[Notices]
[Page 6824]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03540]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Medical Technology Enterprise Consortium

    Notice is hereby given that, on January 28, 2019, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Medical Technology 
Enterprise Consortium (``MTEC'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, Worcester Polytechnic Institute, 
Worcester, MA; Odyssey Systems Consulting Group, Ltd., Wakefiled, MA; 
Serpin Pharma, Nokesville, VA; Csymplicity Software Solutions, Inc., 
Allentown, PA; Qrons, Inc., Miami, FL; Intelligent Optical Systems, 
Inc., Torrance, CA; Abfero Pharmaceuticals Inc., Boston, MA; Shamrock 
Medical LLC, Phoenix, AZ; Sleep Care, Inc., Columbus, OH; Solution 
Guidance Corporation, Chantilly, VA; Existential Technologies, Inc., 
Chula Vista, CA; Bionica Labs LLC, Richmond, VA; Acell, Inc., Columbia, 
MD; Awarables Inc., Baltimore, MD; Onera BV, AB Eindhoven, THE 
NETHERLANDS; Healios, Inc., Flemington, NJ; Sanofi Pasteur, Swiftwater, 
PA; Biobeat Technologies Ltd., Petach Tikva, ISRAEL; Sana Health, Inc., 
San Anselmo, CA; ThoraXS Israel 17 Ltd, Tzur hadassa, ISRAEL; ADM 
Tronics Unlimited, Inc., Northvale, NJ; Aktivax, Inc., Broomfield, CO; 
XSurgical, Inc., Ipswich, MA; 98point6 Inc., Seattle, WA; University of 
Montana, Missoula, MT; Engility Corporation, Chantilly, VA; Entasis 
Therapeutics, Waltham, MA; Thomas Jefferson University, Philadelphia, 
PA; Gryphon Bio, Inc., South San Francisco, CA; Arcos, Inc., and 
Missouri City, TX; have been added as parties to this venture.
    Also, Actuated Medical, Inc., Bellefonte, PA; Disarm Therapeutics, 
Inc., Cambridge, MA; Global Virus Network, Inc., Baltimore, MD; Health 
Research, Inc.--Wadsworth Center, Menands, NY; Parsons Government 
Services Inc., Pasadena, CA; Perceptronics Solutions, Inc., Sherman 
Oaks, CA; Tallinn University of Technology, Tallin, ESTONIA; The 
Regents of the University of Michigan, Ann Arbor, MI; and The 
Washington University, St. Louis, MO; have withdrawn as parties to this 
venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and MTEC intends to file additional 
written notifications disclosing all changes in membership.
    On May 9, 2014, MTEC filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on June 9, 
2014 (79 FR 32999).
    The last notification was filed with the Department on October 12, 
2018. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on November 2, 2018 (83 FR 55204).

Suzanne Morris,
Chief, Premerger and Division Statistics Unit, Antitrust Division.
[FR Doc. 2019-03540 Filed 2-27-19; 8:45 am]
BILLING CODE 4410-11-P